New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
09:04 EDTALXAFDA PDUFA Date for Adasuve
The FDA assigned a Prescription Drug User Fee Act (PDUFA) action date for Alexza Pharmaceuticals' New Drug Application (NDA) for ADASUVE for treatment of agitation associated with schizophrenia or bipolar disorder in adults of December 21. 2012.
News For ALXA From The Last 14 Days
Check below for free stories on ALXA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2014
09:05 EDTALXAAlexza Pharmaceuticals updates five post-EMA approval studies for Adasuve
Subscribe for More Information
August 8, 2014
10:00 EDTALXAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:01 EDTALXAAlexza Pharmaceuticals announces launch of ADASUVE
Subscribe for More Information
06:38 EDTALXAAlexza Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
Subscribe for More Information
August 7, 2014
16:44 EDTALXAAlexza Pharmaceuticals reports Q2 EPS (34c), consensus (67c)
Reports Q2 revenue $1.5M, consensus $2.24M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use